Group One Trading, L.P. Cor Medix Inc. Transaction History

Group One Trading, L.P.

  • $2.68 Billion
  • Q2 2025

A detailed history of Group One Trading, L.P. transactions in Cor Medix Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 27,494 shares of CRMD stock, worth $307,932. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,494
Previous 90,218 69.52%
Holding current value
$307,932
Previous $555,000 39.1%
% of portfolio
0.01%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$5.86 - $16.56 $367,562 - $1.04 Million
-62,724 Reduced 69.52%
27,494 $338,000
Q1 2025

May 14, 2025
SELL
$6.16 - $12.57 $1.37 Million - $2.79 Million
-221,863 Reduced 71.09%
90,218 $555,000
Q4 2024

Feb 14, 2025
SELL
$8.1 - $13.59 $78,570 - $131,823
-9,700 Reduced 3.01%
312,081 $2.53 Million
Q3 2024

Nov 14, 2024
BUY
$3.64 - $8.23 $995,230 - $2.25 Million
273,415 Added 565.3%
321,781 $2.6 Million
Q2 2024

Aug 14, 2024
BUY
$4.08 - $6.39 $98,070 - $153,596
24,037 Added 98.8%
48,366 $209,000
Q1 2024

May 10, 2024
SELL
$2.94 - $4.24 $48,956 - $70,604
-16,652 Reduced 40.63%
24,329 $103,000
Q4 2023

Feb 14, 2024
SELL
$3.0 - $4.01 $24,525 - $32,781
-8,175 Reduced 16.63%
40,981 $154,000
Q3 2023

Nov 09, 2023
SELL
$3.6 - $4.46 $19,832 - $24,570
-5,509 Reduced 10.08%
49,156 $181,000
Q2 2023

Aug 09, 2023
BUY
$3.94 - $5.8 $169,423 - $249,405
43,001 Added 368.66%
54,665 $216,000
Q1 2023

May 12, 2023
SELL
$3.22 - $4.61 $16,740 - $23,967
-5,199 Reduced 30.83%
11,664 $48,000
Q4 2022

Feb 09, 2023
SELL
$2.81 - $4.45 $62,663 - $99,235
-22,300 Reduced 56.94%
16,863 $71,000
Q3 2022

Nov 09, 2022
BUY
$2.82 - $7.52 $110,439 - $294,505
39,163 New
39,163 $111,000
Q4 2021

Feb 11, 2022
SELL
$4.47 - $5.56 $13,713 - $17,058
-3,068 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$4.46 - $7.11 $13,683 - $21,813
3,068 New
3,068 $14,000
Q1 2021

May 12, 2021
SELL
$6.84 - $17.58 $87,661 - $225,305
-12,816 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$5.0 - $9.15 $64,080 - $117,266
12,816 New
12,816 $95,000
Q3 2020

Nov 12, 2020
SELL
$3.96 - $6.15 $13,832 - $21,481
-3,493 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$3.08 - $6.56 $10,758 - $22,914
3,493 New
3,493 $22,000
Q1 2020

May 13, 2020
SELL
$2.35 - $7.08 $83,511 - $251,601
-35,537 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$4.96 - $7.75 $73,918 - $115,498
14,903 Added 72.23%
35,537 $259,000
Q3 2019

Nov 12, 2019
BUY
$6.38 - $9.69 $131,644 - $199,943
20,634 New
20,634 $132,000

Others Institutions Holding CRMD

# of Institutions
181
Shares Held
32.7M
Call Options Held
867K
Put Options Held
561K
View Full List

About CorMedix Inc.

CRMD Quotes by TradingView
  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $462M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email